3545 results for «224»
3545 results
Cracking calcium: best practices to integrate intravascular lithotripsy into your calcium management algorithm
07 Oct 2022 – From AICT-ASIAPCR 2022
With this session, keep up to date on the evidence, trials and outcome data for intravascular lithotripsy in severely calcified lesions. Learn how to use this technique in real-world patients and understand its role in the treatment algorithm for severely calcified coronary lesions.
Beginning with the end in mind - FFR vs. IVUS imaging
06 Oct 2022 – From AICT-ASIAPCR 2022
Consult this session if you want to explore different plaque modification techniques and technology and see how to maximise PCI outcome with IVUS imaging. Also assess when to select FFR to determine when to treat vs. IVUS to determine where and how to treat.
AsiaPCR/SingLIVE 2017: closing Ceremony and Awards
21 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Closing ceremony and awards session from AsiaPCR/SingLIVE 2017, where W. Wijns addresses the subject of what to expect in the field of Interventional Cardiology in 2017, and the speakers present the award winners of this year's best clinical cases namely R. Fukuhara, Japan, W....
Chairperson
Chairperson
Welcome introduction
15 May 2017 – From PCR Innovators Day 2017
Discover the latest innovative and disruptive technologies and key opinion leaders in interventional cardiology during the opening ceremony by W Wijns during PCR Innovators Day Paris 2017.
EAPCI Fellows Course - Opening
15 May 2017 – From EuroPCR 2017
Welcome to the European Interventional Cardiology Fellows Course - Opening, consult this session if you want to find out more about the course hosted by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on Monday 15 and Tuesday morning 16 May.
These presentations were part of the EAPCI...
EuroPCR 2017 Opening Ceremony
16 May 2017 – From EuroPCR 2017
A warm welcome from the Course Directors J. Bax, J. Fajadet, W. Wijns to everyone attending the 2017 edition of EuroPCR that marks 40 years in Angioplasty. Enjoy the Course!
EuroPCR 2017 Nurses and Allied Professionals Programme Closing Ceremony
19 May 2017 – From EuroPCR 2017
Consult the session on the Closing Ceremony of the EuroPCR 2017 Nurses and Allied Professionals Programme, presented by S. Coelho, H. Eltchaninoff and D. Sparv. The State-of-the-art lecture on structural heart disease by Prof. A. Cribier sheds light on LAA occlusion.
EuroPCR 2017 Closing Ceremony
19 May 2017 – From EuroPCR 2017
Opening ceremony
08 Apr 2017 – From PCR Tokyo Valves 2017
Closing Ceremony and Awards
09 Apr 2017 – From PCR Tokyo Valves 2017
AsiaPCR/SingLIVE 2017: Opening Ceremony
19 Jan 2017 – From AsiaPCR/SingLIVE 2017
Consult the Opening ceremony of the AsiaPCR/SingLIVE 2017 course edition, the Chien Foundation Award for outstanding lectureship and lifetime achievement in PCI is awarded to Prof. A. Seth.
Chairperson
Clinical outcomes after TAVI: Session 2
29 Nov 2022 – From PCR London Valves 2022
Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!
Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?
29 Nov 2022 – From PCR London Valves 2022
Watch these presentations to better understand what's happening in the field of tricuspid valve intervention and to appreciate the characteristics of current and newly emerging transcatheter devices.
TAVI in TAVI
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of challenging cases in this session: valve-in-valve in a previous TAVR with healed endocarditis and aortic pseudoaneurysm closure, one-year SAPIEN 3 ultra failure treated with TAV-in-TAV with an Evolut Pro+ system, transcatheter valve implantation and coronary protection in a patient with prior valve-in-valve, and...
Mitral valve-in-valve interventions
Discover various compelling mitral valve-in-valve interventions in this session: bioprosthetic valve dislodgment during transapical valve-in-valve-TMVR, surgical bioprosthetic valve fracture for optimising haemodynamics of mitral valve-in-valve procedure, valve-in-valve TMVR in rheumatic mitral stenosis, and more!
Transcatheter tricuspid interventions: emerging evidence
29 Nov 2022 – From PCR London Valves 2022
Get insights into the latest studies regarding transcatheter tricuspid interventions with this selection of presentations on TriCLASP, bRIGHT, PASTE, EVALUATE, and more!
Mitral innovations
29 Nov 2022 – From PCR London Valves 2022
Discover some innovative mitral interventions with this selection of cases: transcatheter mitral edge-to-edge repair under intracardiac echocardiography only, MitraClip procedure and other structural heart interventions in augmented reality, 3D simulation to guide TMVR in a patient with prior rheumatic heart disease and aortic dissection, and more!
TAVI complications: Session 4
29 Nov 2022 – From PCR London Valves 2022
With this selection of challenging cases, discover how to face various TAVI complications, such as: annular perforation, lost wire, aortoiliac rupture, bilateral coronary ostial occlusion, and much more!
Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case
29 Nov 2022 – From PCR London Valves 2022
Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:
- LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
The operators...
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
